Obesity has become a global health challenge and associated with several comorbidities that include: certain cancers, dyslipidemia, cardiovascular morbidity, type 2 diabetes and reduced overall quality of life.

Weight loss is recommended for type 2 diabetics as it can improve glycemic control and other risk factors.

Patients with type 2 diabetes usually have a reduced response to weight loss.

Saxenda (liraglutide) has become a popular aid for diabetes patients looking to lose weight. In simple terms, Saxenda makes you feel full after you eat. By eating less, patients have resulted in rapid weight loss.

Saxenda